COVID19
Govt allocates addl 1,21,000 vials of Amphotericin-B to states, UTs, central institutions
The government allocated additional 1,21,000 vials of Amphotericin-B to various states, Union Territories (UTs) and central institutions on Friday, according to Union minister Sadananda Gowda. Amphotericin-B is used to treat mucormycosis, also known as black fungus infection.
“Additional 1,21,000 vials of #Amphotericin-B have been allocated to all the States/UTs and Central Institutions today,” the Minister for Chemicals & Fertilizers said in a tweet.
Earlier on June 1, Gowda had said that 2,70,060 vials of Amphotericin B have been allocated to States/UTs & Central Institutions from May 11 to May 30. This is in addition to the supplies of 81,651 vials that had been made by manufacturers to States in the first week of May.
Also Read: Supreme Court terms Centre’s vaccination policy as ‘arbitrary and irrational’ | 7 key points
Mucormycosis affects the sinuses, brain and lungs, and can be life-threatening in diabetic or severely immuno-compromised individuals such as cancer patients or people with HIV/AIDS.
The doctors in India are documenting an alarming number of cases of mucormycosis among patients with COVID and those who have recently recovered.